Tuesday, September 24, 2019
- 1:45pm-3:15pm
-
Alternating bilateral deep brain stimulation in the internal pallidum and subthalamic nucleus in isolated segmental dystonia: a case report
Dystonia · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Ambroxol treatment of primary macrophages derived from patients with GBA-associated Parkinson’s disease
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Ambulatory monitoring of electrodermal activity (EDA) and Heart Rate Variability (HRV) for prediction of motor fluctuations in Parkinson’s Disease (PD)
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Amimia in Parkinson’s Disease and its Relationship with Motor and Non-Motor Symptoms
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Amylin and insulin in Parkinson’s disease patients: a clinical and metabolic study
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Amylin deposition in the brain of Parkinson’s disease patients
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Amylin single-nucleotide polymorphism and Parkinson’s disease
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
An atypical and interesting feature of Parkinson´s disease
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
An examination of real-world onabotulinumtoxinA utilisation for the treatment of lower limb spasticity: The Adult Spasticity International Registry (ASPIRE) study
Spasticity · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
An examination of real-world onabotulinumtoxinA utilization for the treatment of upper limb spasticity: The Adult Spasticity International Registry (ASPIRE) study
Spasticity · Les Muses Terrace, Level 3
- «Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 69
- Next Page»